Tag: Covaxin
17 Results
-
Covaxin’s overall efficacy found 78% against Covid-19, 65% against Delta variant
Efficacy determined under 18-59 age group was 79.4% in symptomatic Covid-19 situation while it reduced to 67.8% among participants aged 60 and above in similar situation.
July 3, 2021 -
Covaxin effectively neutralises Alpha, Beta variant: US study
Covaxin comprises a disabled form of SARS-CoV-2 that cannot replicate but still stimulates the immune system to make antibodies against the virus
June 30, 2021 -
Odisha: 274 fully vaccinated people contract COVID-19 after receiving double doses
It is anticipated that even with administration of effective authorized vaccines, breakthrough cases are expected to happen, till the immunity reaches sufficient levels among the population to further decrease transmission.
June 25, 2021 -
Small hospitals scramble for vaccines, buy jabs from large centres at premium
VIMHANS hospital is getting the doses of Covaxin at Rs 1,310 from a corporate hospital based in Noida.
June 21, 2021 -
Bharat Biotech dispatches Covaxin to 16 states
The company's co-founder and joint managing director Suchitra Ella on Wednesday tweeted that Andhra Pradesh, Assam, Delhi, Gujarat, Karnataka, Madhya Pradesh, Maharashtra, Tamil Nadu, and Telangana were supplied the vaccines through the government of India from June 8 to 14.
June 16, 2021 -
Rs 150/dose for Covaxin not sustainable: Bharat Biotech
The Hyderabad-based vaccine manufacturing company said a higher price in private markets is required to offset part of the costs.
June 15, 2021 -
Delhi AIIMS to begin Covaxin trial on children from Tuesday
Participants would be given the vaccine after their screening report comes. The trial would ensure if the Bharat Biotech jab is suitable for children.
June 14, 2021 -
Covaxin’s Phase 3 trials results likely next month
Covaxin manufacturer Bharat Biotech said its service provider, IQVIA, has started final statistical analysis.
June 10, 2021 -
Sigh of relief: 8 days of Covishield & 2nd dose of Covaxin stock arrives for 18-44 category
Senior Aam Aadmi Party (AAP) leader and MLA Atishi informed while presenting vaccination bulletin digitally on Wednesday that around 1.5 lakh doses of Covishield and Covaxin for 18-44 category have arrived in Delhi.
June 9, 2021 -
India looks forward to WHO’s approval for Covaxin: Foreign Secretary
Noting that vaccines have complex supply chains, he said India has worked to ease regulatory disruptions to these supply chains with key partners through diplomatic interventions.
June 4, 2021 -
After Monday, no Covaxin available for second doses for those in 45+ category: Delhi govt
Entire immunisation of 18-44 olds in Delhi will be temporarily shut after Monday due to shortage of vaccines and the entire vaccination programme for 18-44 olds will be temporarily stopped in all government schools.
May 24, 2021 -
DCGI gives nod to Phase II-III clinical trial of Covaxin on 2 to 18-years-old
The committee after detailed deliberation recommended for grant of permission to conduct the proposed Phase II-III clinical trial to certain conditions.
May 13, 2021 -
Expert panel gives nod to Bharat Biotech’s Covaxin for phase 2/3 trials on 2-18 year-olds
The vaccine has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)
May 12, 2021 -
Covaxin stock over in Delhi, 125 vaccination centres on verge of shutdown
AAP MLA Atishi informed that Delhi has run out of its Covaxin stock for people in the 18-44 age group and the government will be forced to shut down as many as 125 vaccination centres if fresh supply is not received.
May 12, 2021 -
Delhi left with just one stock of Covaxin: Satyendar Jain
The Minister’s remarks came a day after Chief Minister Arvind Kejriwal urged the Centre to direct manufacturers to increase vaccine supplies to the capital between May and July.
May 10, 2021 -
Biotech slashes Covaxin price for states to 400/jab
Serum Institute on Wednesday slashed the price of its Covishield vaccine to Rs 300 per dose from the earlier Rs 400 for states.
April 30, 2021 -
India records 2,61,500 new COVID-19 cases, 1501 deaths in last 24 hours
The Drug Controller General of India (DCGI) approved the use of the Russian Sputnik V vaccine against coronavirus in the country on April 12. Now, India has three vaccines Covishield, Covaxin, and Sputnik V for its inoculation programme against COVID-19.
April 18, 2021